Drug Discovery 2014

Thomas Franch

No Image
Thomas Franch
Nuevolution
Speaker

Presentations at Drug Discovery 2014

Profile of Thomas Franch

Biog:
Thomas Franch, CSO, Nuevolution. He joined Nuevolution in 2001 and has headed the companys encoding technology developments since 2004. He has served as CSO since 2012. Prior to joining Nuevolution, he co-founded RNA Tech Aps working with artificial antisense molecules for therapeutic applications. He holds a Ph.D in Molecular Biology from The University of Southern Denmark (SDU).

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'